Yuta Kodama
Ogaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: Nonsteroidal anti-inflammatory drug use is associated with improved activities of daily living and rehabilitation in older adult patients following a fracture: a retrospective cohort study.
Journal: Journal of pharmaceutical health care and sciences
Published: May 30, 2025
Nonsteroidal anti-inflammatory drug use is associated with improved activities of daily living and rehabilitation in older adult patients following a fracture: a retrospective cohort study.
Journal: Journal of pharmaceutical health care and sciences
Published: November 14, 2024
PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma.
Journal: Cancer science
Published: November 06, 2024
Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.
Journal: Therapeutic advances in medical oncology
Published: May 01, 2024
Recurrent Verruconis gallopava Infection at One Year after Excision of a Solitary Pulmonary Lesion.
Journal: Internal medicine (Tokyo, Japan)
Published: September 04, 2023
Comprehensive circulating microRNA profile as a supersensitive biomarker for early-stage lung cancer screening.
Journal: Journal of cancer research and clinical oncology
Published: January 31, 2023
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis.
Journal: BMC cancer
Published: March 09, 2022
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.
Journal: Cancer science
Published: February 22, 2021
Pharmacist medication instructions are associated with continued medication self-management in older adults: a retrospective observational study.
Journal: Journal of pharmaceutical health care and sciences
Published: October 20, 2020
UHRF1, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer.
Journal: Cancer investigation
Published: March 28, 2020
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
Journal: Clinical lung cancer
Published: July 31, 2019
Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 30, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026